Paroxetine hydrochloride vs. Escitalopram oxalate: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Paroxetine hydrochloride and Escitalopram oxalate. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 318,076 people who take Paroxetine hydrochloride and Escitalopram oxalate, and is updated regularly.
What is Paroxetine hydrochloride?
Paroxetine hydrochloride has active ingredients of paroxetine hydrochloride. It is often used in depression. eHealthMe is studying from 10,426 Paroxetine hydrochloride users. Check the latest studies of Paroxetine hydrochloride.
What is Escitalopram oxalate?
Escitalopram oxalate has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 17,930 Escitalopram oxalate users. Check the latest studies of Escitalopram oxalate.
318,076 people who take Paroxetine hydrochloride and Escitalopram oxalate are studied.
Drugs being compared in this study:
- Escitalopram Oxalate (escitalopram oxalate)
- Paroxetine Hydrochloride (paroxetine hydrochloride)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Paroxetine Hydrochloride:
- not at all: 4.5 %
- somewhat: 19.04 %
- moderate: 33.76 %
- high: 31.08 %
- very high: 11.62 %
Escitalopram Oxalate:
- not at all: 3.52 %
- somewhat: 19.66 %
- moderate: 37.04 %
- high: 30.12 %
- very high: 9.66 %
Want to compare Paroxetine hydrochloride with Escitalopram oxalate?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
Related studies
Alternative drugs to, pros and cons of:
- Paroxetine hydrochloride (9,482 reports)
- Escitalopram oxalate (17,508 reports)
Browse all side effects of Paroxetine hydrochloride:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Escitalopram oxalate:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on paroxetine hydrochloride and escitalopram oxalate (the active ingredients of Paroxetine hydrochloride and Escitalopram oxalate, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Metaglip vs. Avandamet, side effect and effectiveness comparison - a second ago
- Vitamin D3 vs. Vitamin K, side effect and effectiveness comparison - 2 seconds ago
- Periactin vs. Citalopram Hydrobromide, side effect and effectiveness comparison - 3 seconds ago
- Medroxyprogesterone Acetate vs. Methadone Hydrochloride, side effect and effectiveness comparison - 3 seconds ago
- Bisoprodol Fumarate vs. Zetia, side effect and effectiveness comparison - 5 seconds ago
- Could Centrum Silver cause Anhedonia? - 8 seconds ago
- Erythro-Statin vs. Coq-10, side effect and effectiveness comparison - 11 seconds ago
- Fish Oil vs. Warfarin Sodium, side effect and effectiveness comparison - 13 seconds ago
- Triumeq vs. Atazanavir Sulfate, side effect and effectiveness comparison - 14 seconds ago
- Estrostep Fe vs. Mili, side effect and effectiveness comparison - 16 seconds ago